<?xml version="1.0" encoding="UTF-8"?>
<ref id="B132">
 <label>132.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Prokunina-Olsson</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Alphonse</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Dickenson</surname>
    <given-names>RE</given-names>
   </name>
   <name>
    <surname>Durbin</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Glenn</surname>
    <given-names>JS</given-names>
   </name>
   <name>
    <surname>Hartmann</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>COVID-19 and emerging viral infections: the case for interferon lambda</article-title>. 
  <source>J Exp Med.</source> (
  <year>2020</year>) 
  <volume>217</volume>:
  <fpage>e20200653</fpage>. 
  <pub-id pub-id-type="doi">10.1084/jem.20200653</pub-id>
  <?supplied-pmid 32289152?>
  <pub-id pub-id-type="pmid">32289152</pub-id>
 </mixed-citation>
</ref>
